It plays a critical role in neutralizing free radicals, detoxifying the liver, and supporting immune function
Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
10.1016/j.jcte.2014.03.001 47
Soliman OAE, Mohamed EAM, El-Dahan MS, Khatera NAA
They need a plan that accounts for the fact that healthy weight loss should support activity, not make activity harder
Whether clinical trial participation is appropriate and available for your situation